FDA Inspection 983201 — Carter Bloodcare - Denton
The FDA completed an inspection of Carter Bloodcare - Denton on August 15, 2016 in Denton, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 15, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Denton, TX (United States)